Nishant Agrawal Profile
Nishant Agrawal

@HNCancerDoc

Followers
179
Following
604
Media
2
Statuses
146

Surgeon, scientist, father, dreamer, team-player, and compassionate idealist

Joined November 2021
Don't wanna be here? Send us removal request.
@HNCancerDoc
Nishant Agrawal
1 year
RT @UCCancerCenter: Experts at @UChicagoMed successfully treated and cured stage IV oral cancer patient Pat Sirvinskas with a unique approa….
Tweet card summary image
uchicagomedicine.org
Head and neck cancer specialists at the University of Chicago Medicine were able to save a woman's tongue, despite her complex stage 4 tongue cancer case.
0
5
0
@HNCancerDoc
Nishant Agrawal
1 year
RT @UCCancerCenter: We are proud to announce that @UCCancerCenter has been ranked #1 in Illinois and #12 in the nation in the latest U.S. N….
0
3
0
@HNCancerDoc
Nishant Agrawal
1 year
RT @UChicagoMed: U.S. News & World Report's Best Hospitals list ranked University of Chicago Medical Center's Cancer and ENT programs highe….
0
11
0
@HNCancerDoc
Nishant Agrawal
1 year
RT @UChicagoOHNS: A truly special night celebrating the graduation of our chief residents Drs. Warren and Patel! They were a special duo w….
0
3
0
@HNCancerDoc
Nishant Agrawal
1 year
RT @lab_pearson: @AriRosenbergMD #OPTIMA2 HNSCC DE-ESCALATION study out today @JAMAOnc:. 🧑‍🤝‍🧑Broad inclusion N2 to N3 and/or T3 to T4 HPV+….
0
5
0
@HNCancerDoc
Nishant Agrawal
1 year
RT @UCCancerCenter: @AriRosenbergMD presents results from HB-200, an arenavirus-based vector therapy specifically targeted for HPV+ orophar….
0
4
0
@HNCancerDoc
Nishant Agrawal
1 year
RT @lab_pearson: @AriRosenbergMD at #asco24 sharing a first look at TARGET-HPV. Exciting HPV targeted chemo-immunotherapy neoadjuvant treat….
0
5
0
@HNCancerDoc
Nishant Agrawal
1 year
RT @UCCancerCenter: Manu Sundaresan, 4th year undergrad student @UChicago presents an excellent poster at #AACR24 showing the association o….
0
3
0
@HNCancerDoc
Nishant Agrawal
1 year
RT @UCCancerCenter: Congratulations to Alka Singh on receiving “AACR Scholar in Training Award” for presenting important work on “Comprehen….
0
4
0
@HNCancerDoc
Nishant Agrawal
2 years
RT @UChicagoOHNS: So excited that Drs. Roxbury, Baroody, Shogan, Portugal, Pinto, @EAB_ENT @HNCancerDoc @GluthMichael @DrDanaSuskind have m….
0
3
0
@HNCancerDoc
Nishant Agrawal
2 years
RT @TedImbEARy: An all star squad! #ChicagoTopDocs.
0
1
0
@HNCancerDoc
Nishant Agrawal
2 years
RT @AriRosenbergMD: ctDNA is a powerful dynamic biomarker with IO-based treatment; Need for prospective ctDNA adaptive immunotherapy trial….
0
8
0
@HNCancerDoc
Nishant Agrawal
2 years
RT @hncalliance: Has your head and neck tumor grown back? We are looking for people with a diagnosis of head and neck cancer caused by huma….
0
3
0
@HNCancerDoc
Nishant Agrawal
2 years
RT @hncalliance: Attention head and neck cancer fighters, survivors, and caregivers! Register now for the 2023 Head and Neck Cancer Symposi….
0
2
0
@HNCancerDoc
Nishant Agrawal
2 years
RT @UChicagoOHNS: Please join us on Saturday September 2nd for our virtual #ENT program showcase! RSVP with the link below - Excited to me….
Tweet card summary image
canva.com
Login to access and create your next design.
0
2
0
@HNCancerDoc
Nishant Agrawal
2 years
RT @DrDanaSuskind: AI devices are almost certain to become electronic babysitters—just as previous generations of parents (understandably!)….
Tweet card summary image
wsj.com
Sophisticated artificial-intelligence helpers will relieve parents’ burdens and give babies and toddlers the back-and-forth stimulation they need. But will there be a developmental cost?
0
23
0
@HNCancerDoc
Nishant Agrawal
2 years
RT @UChicagoOHNS: Proud to announce we have been ranked 32 nationally among #ENT programs in the @usnews annual report! This is a collecti….
0
4
0
@HNCancerDoc
Nishant Agrawal
2 years
RT @hncalliance: Don't miss (August 21st) our next free webinar - "Caregivers - How to care for yourself and your loved one with head and n….
0
1
0
@HNCancerDoc
Nishant Agrawal
2 years
RT @hncalliance: Join us for our 2023 Head & Neck Cancer Symposium. Enjoy informative sessions, survivor stories, & opportunities to connec….
0
4
0